Tiziana Life Sciences Ltd (TLSA) Stock Analysis

Tiziana Life Sciences Ltd (TLSA) is a publicly traded company in the HEALTHCARE sector. It trades at $1.36, carries a market capitalization of $178.16M. This page summarizes the public market data, fundamentals, and frequently asked questions for TLSA, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

Market Sentiment

Tiziana Life Sciences Ltd currently has a Bullish sentiment score of 0.30.

About Tiziana Life Sciences Ltd

Tiziana Life Sciences Ltd is a clinical-stage biotechnology company that specializes in the discovery and development of innovative therapeutic molecules and diagnostics aimed at addressing unmet medical needs in oncology and immunology. Headquartered in the UK, the company is leveraging its proprietary technologies to advance a pipeline of novel therapeutics, including treatment candidates for various cancers and autoimmune diseases. With a strong focus on science and patient outcomes, Tizia...

GNG Research Analysis

GNG Research scores Tiziana Life Sciences Ltd (TLSA) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for TLSA.

Frequently Asked Questions

Does TLSA pay dividends?

Tiziana Life Sciences Ltd (TLSA) does not currently pay a regular dividend.

What is TLSA's market cap?

Tiziana Life Sciences Ltd (TLSA) has a market capitalization of $178.16M with a current stock price of $1.36.